Abstract
Ligands based on bicyclic peptides can combine favourable properties of antibodies (good binding affinity and target specificity) and small molecule ligands (stability, access to chemical synthesis, diffusion properties) and might be suitable molecular structures for the development of therapeutics. By using a combinatorial methodology based on phage display and a chemical cyclisation reaction, we are generating bicyclic peptide antagonists of protein targets with therapeutic applications in mind. © Schweizerische Chemische Gesellschaft.
Author supplied keywords
Cite
CITATION STYLE
Heinis, C. (2011). Bicyclic peptide antagonists derived from genetically encoded combinatorial libraries. Chimia, 65(9), 677–679. https://doi.org/10.2533/chimia.2011.677
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.